|
|
| (422 intermediate revisions by 4 users not shown) |
| Line 1: |
Line 1: |
| {| border="3"
| | [[Syncope]] is classified into three types: |
| |+
| | * [[Cardiac]] |
| ! style="background: #4479BA; width: 150px;" | {{fontcolor|#FFF| Lipomatous tumor}}
| | * [[Neurogenic]] |
| ! style="background: #4479BA; width: 150px;" | {{fontcolor|#FFF| Age of onset}}
| | * [[Vasovagal syncope|vasovagal]] |
| ! style="background: #4479BA; width: 150px;" | {{fontcolor|#FFF| Gender preponderance}}
| |
| ! style="background: #4479BA; width: 150px;" | {{fontcolor|#FFF| Location}}
| |
| ! style="background: #4479BA; width: 150px;" | {{fontcolor|#FFF| Clinical features}}
| |
| ! style="background: #4479BA; width: 150px;" | {{fontcolor|#FFF| Pathologic appearance}}
| |
| ! style="background: #4479BA; width: 150px;" | {{fontcolor|#FFF| Other features}}
| |
| ! style="background: #4479BA; width: 150px;" | {{fontcolor|#FFF| Pathologic view}}
| |
| |-
| |
| ! style="padding: 5px 5px; background: #DCDCDC; " align="left" |Angiolipoma
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| |
| * Second and third decades of life
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| |
| * Female < male
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| |
| * More commonly seen in forearm
| |
| * May also affect trunk and upper arm
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| |
| * Subcutaneous nodule
| |
| * Tender to palpation
| |
| * Less than 2 cm
| |
| | |
| | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| |
| * Encapsulated, yellow nodules with a reddish tinge
| |
| * A combination of fatty tissue and vascular channels
| |
| * Fibrin thrombi is present in vascular channels (characteristic finding)
| |
| | |
| | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| |
| * Benign
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[File:Capture1.PNG|thumb|none|200px|Contributed by Dr. Dharam Ramnani in Webpathology]]
| |
| |-
| |
| ! style="padding: 5px 5px; background: #DCDCDC; " align="left" |Myolipoma
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| |
| * Fifth and sixth decades of life
| |
| | |
| *
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| |
| * Female > male
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| |
| * More commonly seen in retroperitoneum, abdomen, pelvis, inguinal region, or abdominal wall
| |
| * May also affect extremities
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| |
| * Subcutaneous mass which may also engage superficial muscular fascia
| |
| * Size differs depending on the location
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| |
| * Partially encapsulated mass with partially yellow-white cut surface
| |
| * A combination of mature adipocytes and sheets of well-differentiated smooth muscle
| |
| * No nuclear atypia
| |
| *Sieve-like appearance at low magnification (due to interspersed location of smooth muscle component)
| |
| | |
| *
| |
| *
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| |
| * Benign
| |
| * It is usually large and located in the deep soft tissues
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[File:Capture.PNG|thumb|none|200px|Contributed by Dr. Dharam Ramnani in Webpathology]]
| |
| |-
| |
| ! style="padding: 5px 5px; background: #DCDCDC; " align="left" |Myelolipoma
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| |
| * Fifth decade of life
| |
| | |
| *
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| |
| * Female = male
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| |
| * More commonly seen in adrenal glands
| |
| * Other possible locations include:
| |
| * thoracic, retroperitoneum and presacral region, mediastinum, liver, and bone
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| |
| * Usually asymptomatic
| |
| * May cause abdominal pain, nausea, and constipation (depending on the location and size)
| |
| * Uncommonly, may cause retro-peritoneal hemorrhage
| |
| * 3 to 7 cm
| |
| | |
| *
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| |
| * A combination of bone marrow elements and adipose tissue in varying proportions | |
| * May show myxoid changes
| |
| | |
| *
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| |
| * Well-circumscribed radiolucent mass in radiologic imaging
| |
| * May have hromonal activity
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[File:Adrenal Myelolipoma MP CTR.jpg|thumb|none|200px|Contributed by Sarahkayb in Wikimedia commons]]
| |
| |-
| |
| ! style="padding: 5px 5px; background: #DCDCDC; " align="left" |Spindle Cell/Pleomorphic Lipoma
| |
| | |
| | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| |
| * Fifth to seventh decades of life
| |
| | |
| *
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| |
| * Female < male
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| |
| * More commonly seen in posterior neck, shoulder, and back
| |
| * It is also reported in oral cavity
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| |
| * Subcutaneous nodule with firm consistency | |
| * Slowly growing and painless
| |
| * Mostly between 3 to 5 cm
| |
| | |
| *
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| |
| * Similar to ordinary lipoma
| |
| * A combination of mature fat cells and spindle cell or pleomorphic elements
| |
| * Lipomatous component may vary in amount
| |
| | |
| *
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| |
| * Immunohistochemically positive for CD34
| |
| * Benign
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[File:Spindle cell lipoma -- intermed mag.jpg|thumb|none|200px|Contributed by Nephron in Wikimedia commons]]
| |
| |-
| |
| !style="padding: 5px 5px; background: #DCDCDC; " align="left" |Chondroid Lipoma
| |
| | |
| | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| |
| * Third or fourth decade of life
| |
| | |
| *
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| |
| * Female > male
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| |
| * More commonly seen in limbs and limb girdles
| |
| * May also involve trunk, and the head and neck region, particularly the oral cavity
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| |
| * Slowly growing painless mass
| |
| * Sizes ranges from 1 to 11 cm
| |
| | |
| *
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| |
| * Encapsulated tumor with a yellow, white, or pink-tan cut surface
| |
| * A combination of mature adipocytes in association with nests of vacuolated cells in a myxochondroid or hyalinized fibrous background
| |
| | |
| *
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| |
| * Heterogeneous soft tissue mass in radiologic imaging
| |
| * Benign
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[File:Capture2.PNG|thumb|none|200px|Contributed by Dr. Dharam Ramnani in Webpathology]]
| |
| |-
| |
| !style="padding: 5px 5px; background: #DCDCDC; " align="left" |Hibernoma
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| |
| * Third decade of life
| |
| | |
| *
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| |
| * Female = male
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| |
| * Most commonly seen in thigh
| |
| * May also affect shoulder, back, neck, chest, arm, and abdominal cavity/retroperitoneum
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| |
| * Slowly growing, painless, subcutaneous mass
| |
| * Affects intramuscular in 10% of the cases
| |
| *Size varies between 5 to 15 cm
| |
| | |
| *
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| |
| * Well-defined, soft, and mobile mass
| |
| * A combination of vacuolated granular eosinophilic cells with abundant mithochondria and high vascular content
| |
| | |
| *
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| |
| * Immunohistochemically positive for S-100
| |
| * Benign | |
| | style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[File:Hibernoma2.jpg|thumb|none|200px|Contributed by Nephron in Wikimedia commons]]
| |
| |-
| |
| ! style="padding: 5px 5px; background: #DCDCDC; " align="left" |Lipomas of Tendon Sheaths and Joints
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| |
| * Second and third decades of life
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| |
| |
| |
| |-
| |
| ! style="padding: 5px 5px; background: #DCDCDC; " align="left"|Intramuscular and Intermuscular Lipomas
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| |
| |
| |
| |-
| |
| ! style="padding: 5px 5px; background: #DCDCDC; " align="left"|Neural Fibrolipoma
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| |
| |
| |
| |}
| |
| | |
| | |
| ===Example #1===
| |
| The patient presented with S.O.B. one year after hysterectomy for a leiomyomatous uterus.
| |
| <div align="left">
| |
| <gallery heights="175" widths="175">
| |
| Image:Intravascular-extension-leiomyoma-001.jpg|CT in Intravenous leiomyomatosis
| |
| Image:Intravascular-extension-leiomyoma-002.jpg
| |
| </gallery>
| |
| </div>
| |
| <div align="left">
| |
| <gallery heights="175" widths="175">
| |
| Image:Intravascular-extension-leiomyoma-003.jpg
| |
| Image:Intravascular-extension-leiomyoma-004.jpg
| |
| </gallery>
| |
| </div>
| |
| <div align="left">
| |
| <gallery heights="175" widths="175">
| |
| Image:Intravascular-extension-leiomyoma-005.jpg
| |
| Image:Intravascular-extension-leiomyoma-006.jpg
| |
| </gallery>
| |
| </div>
| |
| | |
| <div align="left">
| |
| <gallery heights="175" widths="175">
| |
| Image:Intravascular-extension-leiomyoma-007.jpg
| |
| Image:Intravascular-extension-leiomyoma-008.jpg
| |
| </gallery>
| |
| </div>
| |
| <references />
| |